Virax Biolabs Group • VRAX
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. James Foster$1.6M
Market Cap • 18/04/20242021
(há 3 anos)
2022
(2 years ago)
NASDAQ
Listagem
London
5
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
VRAXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.